Abstract

You have accessJournal of UrologyAdrenal/Single Port Surgery/LESS/NOTES1 Apr 2015V11-13 LAPAROENDOSCOPIC SINGLE SITE NEPHROURETERECTOMY: TECHNIQUE & INITIAL EXPERIENCE Jenna She, Alison Rutledge, and Albert Tiu Jenna SheJenna She More articles by this author , Alison RutledgeAlison Rutledge More articles by this author , and Albert TiuAlbert Tiu More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2015.02.2611AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Open radical nephroureterectomy remains the “gold standard” treatment for upper urinary tract urothelial carcinoma. Laparoendoscopic single site (LESS) nephroureterectomy has raised significant interest worldwide to reduce morbidity and scarring associated with conventional laparoscopy. The objective of this study is to investigate the techniques, safety and feasibilities of LESS nephroureterecomy for upper urinary tract urothelial carcinoma. METHODS We retrospectively reviewed a prospectively maintained database to identify patients who underwent laparoendoscopic single site nephroureterectomy for upper urinary tract urothelial carcinoma. Perioperative data were recorded along with functional and oncological outcomes. Our technique was performed using the GelPOINT device (Applied Medical, Rancho Santa Margarita, CA, USA) through a peri-umbilical incision. We placed four ports into the GelPOINT (3x10mm and 1x12mm). Our management of the distal ureter and badder cuff mimicked those of the open approach in all cases. The bladder cuff was dissected circumferentially around the ureteric orifice. The bladder defect was closed with continuous running barbed V-Loc (Covidien, Dublin, Ireland). RESULTS A total of three patients were identified (2 female, 1 male) from July 2013 to July 2014. The mean age was 66 years old (59-69 and mean BMI was 26. There were two left sided upper urinary tract tumour and one right sided upper urinary tract tumour. Of these tumours two were located in the upper ureter and one was in the mid ureter. The mean pre-operative and post-operative creatinine was 90 umol/L and 110 umol/L respectively. The mean estimated blood loss was 266 mL and the mean total operative time was 210 minutes. The mean length of hospital stay was 3 days. None of the patients were converted to open surgery. There was one post operative complication of urinary tract infection. None of the patients required blood transfusion. The final histology confirmed one high grade Ta urothelial carcinoma and two high grade T1 urothelial carcinoma. Of the two high grade T1, one has concurrent carcinoma in-situ. There was no positive surgical margin. At the median follow up of 6 months there was no local or distal recurrences CONCLUSIONS Our initial LESS nephroureterectomy experience is comparable to other minimal invasive & open series. There is a potential in the future for long term follow up analysis across multi-institutions. Significant improvements are required to address the current challenges of LESS. Careful selection of patients for LESS nephroureterectomy is crucial © 2015 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 193Issue 4SApril 2015Page: e910-e911 Advertisement Copyright & Permissions© 2015 by American Urological Association Education and Research, Inc.MetricsAuthor Information Jenna She More articles by this author Alison Rutledge More articles by this author Albert Tiu More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call